Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH‐dependent Cushing's syndrome
Summary Background and aim Differential diagnosis between Cushing's Disease (CD) and Ectopic ACTH Syndrome (EAS) may be a pitfall for endocrinologists. The increasing use in clinical practice of chromatography and mass spectrometry improves the measurement of urinary free cortisol (UFF) and cortisone (UFE). We have recently observed that cortisol to cortisone ratio (FEr) was higher in a small series of EAS; in this study we collected a larger number of ACTH-dependent Cushing's Syndrome (CS) to study the role of FEr to characterize the source of corticotropin secretion. Materials and methods High-pressure liquid chromatography with UV detection (HPLC-UV, n=35) or liquid chromatography-tandem mass spectrometry (LC-MS/MS, n=72) were used to measure UFF,UFE and FEr in 83 patients with CD and 24 with EAS. Results UFF,UFE and FEr levels were higher in EAS than in CD (UFF: 6671 vs 549 nmol/24 hours; UFE: 2069 vs 464 nmol/24 hours; FEr: 4.13 vs 0.97; all P<.001). FEr >1.15 (the best ROC-based threshold) was able to distinguish CD from EAS with 75% sensitivity (SE) and 75% specificity (SP), AUC 0.811; results were similar between HPLC-UV (SE 73%, SP 79%, AUC 0.708) and LC-MS/MS (SE 77%, SP 73%, AUC 0.834; P=.727). The diagnostic accuracy of FEr was similar to that of CRH test or high-dose dexamethasone suppression test (respectively P=.171 and P=.683), also combined. Finally, FEr was able to increase the number of correct diagnosis in patients with discordant dynamic tests. Conclusions Urinary FEr >1.15 was able to suggest EAS, with a diagnostic accuracy similar to that of other dynamic tests proposed to study ACTH-dependent CS..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:87 |
|---|---|
| Enthalten in: |
Clinical endocrinology |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ceccato, Filippo [VerfasserIn] |
|---|
| Links: |
|---|
| RVK: |
|---|
| doi: |
10.1111/cen.13391 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1996812041 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1996812041 | ||
| 003 | DE-627 | ||
| 005 | 20230518092128.0 | ||
| 007 | tu | ||
| 008 | 171125s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1111/cen.13391 |2 doi | |
| 028 | 5 | 2 | |a PQ20171228 |
| 035 | |a (DE-627)OLC1996812041 | ||
| 035 | |a (DE-599)GBVOLC1996812041 | ||
| 035 | |a (PRQ)p1331-548e11fbbc17235c399b891410354970d740f9704db511638dcd21aaeaa26fa90 | ||
| 035 | |a (KEY)0012559820170000087000500500diagnosticaccuracyofincreasedurinarycortisolcortis | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 084 | |a XA 10000 |q AVZ |2 rvk | ||
| 084 | |a 44.89 |2 bkl | ||
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Ceccato, Filippo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH‐dependent Cushing's syndrome |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Summary Background and aim Differential diagnosis between Cushing's Disease (CD) and Ectopic ACTH Syndrome (EAS) may be a pitfall for endocrinologists. The increasing use in clinical practice of chromatography and mass spectrometry improves the measurement of urinary free cortisol (UFF) and cortisone (UFE). We have recently observed that cortisol to cortisone ratio (FEr) was higher in a small series of EAS; in this study we collected a larger number of ACTH-dependent Cushing's Syndrome (CS) to study the role of FEr to characterize the source of corticotropin secretion. Materials and methods High-pressure liquid chromatography with UV detection (HPLC-UV, n=35) or liquid chromatography-tandem mass spectrometry (LC-MS/MS, n=72) were used to measure UFF,UFE and FEr in 83 patients with CD and 24 with EAS. Results UFF,UFE and FEr levels were higher in EAS than in CD (UFF: 6671 vs 549 nmol/24 hours; UFE: 2069 vs 464 nmol/24 hours; FEr: 4.13 vs 0.97; all P<.001). FEr >1.15 (the best ROC-based threshold) was able to distinguish CD from EAS with 75% sensitivity (SE) and 75% specificity (SP), AUC 0.811; results were similar between HPLC-UV (SE 73%, SP 79%, AUC 0.708) and LC-MS/MS (SE 77%, SP 73%, AUC 0.834; P=.727). The diagnostic accuracy of FEr was similar to that of CRH test or high-dose dexamethasone suppression test (respectively P=.171 and P=.683), also combined. Finally, FEr was able to increase the number of correct diagnosis in patients with discordant dynamic tests. Conclusions Urinary FEr >1.15 was able to suggest EAS, with a diagnostic accuracy similar to that of other dynamic tests proposed to study ACTH-dependent CS. | ||
| 540 | |a Nutzungsrecht: © 2017 John Wiley & Sons Ltd | ||
| 650 | 4 | |a Ectopic ACTH Syndrome | |
| 650 | 4 | |a cortisone | |
| 650 | 4 | |a Cushing's Disease | |
| 650 | 4 | |a liquid chromatography‐tandem mass spectrometry | |
| 650 | 4 | |a urinary free cortisol | |
| 650 | 4 | |a High-performance liquid chromatography | |
| 650 | 4 | |a Dexamethasone | |
| 650 | 4 | |a Hydrocortisone | |
| 650 | 4 | |a Chromatography | |
| 650 | 4 | |a Secretion | |
| 650 | 4 | |a Cushing's syndrome | |
| 650 | 4 | |a Mass spectrometry | |
| 650 | 4 | |a Accuracy | |
| 650 | 4 | |a Adrenocorticotropic hormone | |
| 650 | 4 | |a Hormones | |
| 650 | 4 | |a Mass spectroscopy | |
| 650 | 4 | |a Differential diagnosis | |
| 650 | 4 | |a Pituitary | |
| 650 | 4 | |a Scientific imaging | |
| 650 | 4 | |a Nervous system diseases | |
| 700 | 1 | |a Trementino, Laura |4 oth | |
| 700 | 1 | |a Barbot, Mattia |4 oth | |
| 700 | 1 | |a Antonelli, Giorgia |4 oth | |
| 700 | 1 | |a Plebani, Mario |4 oth | |
| 700 | 1 | |a Denaro, Luca |4 oth | |
| 700 | 1 | |a Regazzo, Daniela |4 oth | |
| 700 | 1 | |a Rea, Federico |4 oth | |
| 700 | 1 | |a Frigo, Anna Chiara |4 oth | |
| 700 | 1 | |a Concettoni, Carolina |4 oth | |
| 700 | 1 | |a Boscaro, Marco |4 oth | |
| 700 | 1 | |a Arnaldi, Giorgio |4 oth | |
| 700 | 1 | |a Scaroni, Carla |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical endocrinology <Oxford> |d Oxford [u.a.] : Wiley-Blackwell, 1972 |g 87(2017), 5, Seite 500-507 |w (DE-627)129299251 |w (DE-600)121745-8 |w (DE-576)014492032 |x 0300-0664 |7 nnns |
| 773 | 1 | 8 | |g volume:87 |g year:2017 |g number:5 |g pages:500-507 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1111/cen.13391 |3 Volltext |
| 856 | 4 | 2 | |u http://onlinelibrary.wiley.com/doi/10.1111/cen.13391/abstract |
| 856 | 4 | 2 | |u https://search.proquest.com/docview/1955394737 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a XA 10000 |
| 936 | b | k | |a 44.89 |q AVZ |
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 87 |j 2017 |e 5 |h 500-507 | ||